Q3 2024
Read transcript →Arbutus Biopharma Corporation (ABUS)
NASDAQ·Healthcare·Biotechnology
$4.17
-2.69%
Mkt Cap $830.78M
Q2 2024
Read transcript →Q1 2024
Read transcript →Q4 2023
Read transcript →Q3 2023
Read transcript →Q2 2023
Read transcript →Q1 2023
Read transcript →Q4 2022
Read transcript →Q3 2022
Read transcript →Q2 2022
Read transcript →Q1 2022
Read transcript →Q4 2021
Read transcript →Q3 2021
Read transcript →Q2 2021
Read transcript →Q1 2021
Read transcript →Q4 2020
Read transcript →Q3 2020
Read transcript →Q2 2020
Read transcript →Q1 2020
Read transcript →Q4 2019
Read transcript →Q3 2019
Read transcript →Q2 2019
Read transcript →Q1 2019
Read transcript →Q4 2018
Read transcript →Q3 2018
Read transcript →Q2 2018
Read transcript →Q1 2018
Read transcript →Q4 2017
Read transcript →Q3 2017
Read transcript →Q2 2017
Read transcript →Q1 2017
Read transcript →Q1 2016
Read transcript →Q1 2015
Read transcript →Q4 2014
Read transcript →Q3 2014
Read transcript →Q2 2014
Read transcript →Q1 2014
Read transcript →Q3 2013
Read transcript →Q2 2013
Read transcript →Q1 2013
Read transcript →